ADAPTIMMUNE THERAPEUTICS PLC Shareholders' Equity
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) had Shareholders' Equity of -$70.96 million as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-08-13
- 2025-06-30: Stockholders' Equity Attributable to Parent -$70.96M.
- 2025-03-31: Stockholders' Equity Attributable to Parent -$37.43M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $11.85M.
- 2024-09-30: Stockholders' Equity Attributable to Parent $79.99M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-06-30 | -$70.96M 10-Q · filed 2025-08-13 |
| 2025-03-31 | -$37.43M 10-Q · filed 2025-08-13 |
| 2024-12-31 | $11.85M 10-Q · filed 2025-08-13 |
| 2024-09-30 | $79.99M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $96.27M 10-Q · filed 2025-08-13 |
| 2024-03-31 | $24.38M 10-Q · filed 2025-08-13 |
| 2023-12-31 | $39.51M 10-Q · filed 2025-08-13 |
| 2023-09-30 | $88.13M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $126.65M 10-Q · filed 2024-11-13 |
| 2023-03-31 | $83.88M 10-Q · filed 2024-11-13 |
| 2022-12-31 | $81.88M 10-K · filed 2025-03-24 |
| 2022-09-30 | $113.34M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $141.92M 10-Q · filed 2023-11-08 |
| 2022-03-31 | $163.15M 10-Q · filed 2023-11-08 |
| 2021-12-31 | $205.96M 10-K · filed 2025-03-24 |
| 2021-09-30 | $240.98M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $277.94M 10-Q · filed 2022-11-08 |
| 2021-03-31 | $309.16M 10-Q · filed 2022-11-08 |
| 2020-12-31 | $341.23M 10-K · filed 2024-03-06 |
| 2020-09-30 | $376.21M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $407.58M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $186.04M 10-Q · filed 2021-11-04 |
| 2019-12-31 | $123.64M 10-K · filed 2023-03-06 |
| 2019-09-30 | $147.68M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $186.99M 10-Q · filed 2020-11-05 |
| 2019-03-31 | $219.66M 10-Q · filed 2020-11-05 |
| 2018-12-31 | $246.88M 10-K · filed 2022-03-14 |
| 2017-12-31 | $202.98M 10-K · filed 2021-02-25 |
| 2017-09-30 | $228.99M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $229.50M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $208.33M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $166.14M 10-K · filed 2018-03-15 |
| 2016-09-30 | $180.00M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $196.99M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $218.95M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $234.99M 10-K · filed 2018-03-15 |
| 2015-06-30 | $259.00M 10-K · filed 2018-03-15 |
| 2014-06-30 | $2.96M 10-K · filed 2018-03-15 |
| 2013-06-30 | -$2.15M 10-K · filed 2017-03-13 |
| 2012-06-30 | -$124.00K 8-K · filed 2016-07-08 |